by | Jun 26, 2020 | Diamond, Michael, Fremont, Daved, VanBlargan, Laura, Zhao, Haiyan
— Species: Mouse
Target: SARS-CoV-2 spike protein
Applications:
Data: See table below for library of antibodies, inventor can recommend specific clones based on intended application.
Related Web Links: Diamond Profile
Available Antibodies
Ab:
Well #
Final Boost
flow cytometer…
by | Jun 26, 2020 | Azab, Abdel Kareem, Federico, Cinzia, Schwarz, Julie, Sun, Jennifer
— Technology Description
Researchers in Prof. Kareem Azab’s laboratory have developed a fast, localized drug delivery system designed to maximize anti-tumor efficacy and reduce side effects by delivering chemotherapy directly to cervical tumors.
The current standard-of-care treatment regimen …
by | Jun 26, 2020 | Ellebedy, Ali
— Species: Human
Target: SARS-CoV-2 nucleocapsid protein
Applications:
Description: Two recombinant fully human monoclonal antibodies that recognize SARS-CoV-2 spike protein (data below).
Related Web Links: Ellebedy Profile; Ellebedy Lab
by | Jun 26, 2020 | Diamond, Michael, Ellebedy, Ali, Fremont, Daved
— Species: Mouse
Target: SARS-CoV-2 spike protein
Applications:
Description: Four murine monoclonal antibodies that recognize SARS-CoV-2 spike protein. Data below includes avaiable antibodies (mCoV.1.1C02; mCoV.1.2C08; mCoV.1.2D09; mCoV.1.2F05).
Related Web Links: Ellebedy Profile; Ellebedy Lab
…
by | Jun 9, 2020 | Chaudhuri, Aadel, Maher, Christopher, Pachynski, Russell
— Technology Description
A team of researchers at Washington University has developed “EnhanceAR-Seq”, a circulating tumor DNA (ctDNA) assay that predicts which patients are at high risk for developing resistance to androgen receptor (AR)-directed treatment for metastatic prostate cancer…